Xingwu Zhou

9PUBLICATIONS
54CO-AUTHORS
NanomedicineMain group metal chemistryMolecular targetsInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 10, 2026
Oral nano-delivery of a gut microbial metabolite enhances T cell stemness for cancer immunotherapy.

|May 07, 2026
Intermetallic nanoassemblies potentiate systemic STING activation.

|Dec 28, 2025
BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunity.

Wang Gong, Hülya F Taner, Yuesong Wu

|Nov 03, 2025
Reprogramming tumor microenvironment via systemic delivery of TLR3 agonist and manganese nanoparticle.

Young Seok Cho, Xingwu Zhou, Xiaoqi Sun

|Jun 24, 2024
Strategies for the development of metalloimmunotherapies.

Xiaoqi Sun, Xingwu Zhou, Xiaoyue Shi

|May 01, 2024
Differential Bioactivation Profiles of Different GS-441524 Prodrugs in Cell and Mouse Models: ProTide Prodrugs with High Cell Permeability and Susceptibility to Cathepsin A Are More Efficient in Delivering Antiviral Active Metabolites to the Lung.

Jiapeng Li, Daniel Macedo de Melo Jorge, Weiwen Wang

Pageof 2

Frequent Collaborators

8 joint publications

James J Moon

4 joint publications

Yu Leo Lei

4 joint publications

Young Seok Cho

3 joint publications

Qi Wu